搜索结果

Search Results for " tr 2 "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T17149	Tr-PEG2-OH	Others	Others
	Tr-PEG2-OH is a PEG-based PROTAC linker utilized in PROTAC synthesis[1]. It also serves as a non-cleavable 2-unit PEG ADC linker for the synthesis of antibody-drug conjugates (ADCs)[2].
T61464	TRβ agonist 2
	TRβ agonist 2 (Compound 1) is a highly potent agonist of TRβ. Moreover, it effectively reduces lipid accumulation in HepG2 cells and promotes lipolysis, offering comparable effects. With its promising attributes, TRβ agonist 2 emerges as a potential thyromimetics that selectively targets TRβ [1].
T78273	Anti-Mouse TNFR2 Antibody (TR75-54.7)
	Anti-Mouse TNFR2 Antibody为针对小鼠TNFR2的IgG类抗体抑制剂，由Armenian Hamster作为宿主产生。
T37173	MPro Inhibitor 11a
	MProinhibitor 11a is an inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (MPro; IC50= 0.053 μM in a TR-FRET assay).1It reduces viral yield in the culture supernatant of SARS-CoV-2-infected Vero E6 cells (EC50= 0.53 μM). MProinhibitor 11a also reduces viral RNA copy numbers in the same model when used at concentrations ranging from 1.85 to 50 μM. 1.Dai, W., Zhang, B., Jiang, X.-M., et al.Structure-based design of antiviral drug candidates targeting the SARS-...
T82838	BODIPY TR-X BODIPY TR-X NHS Ester
	BODIPY TR-X (BODIPY TR-X NHS Ester) 为荧光染料，用于标定含伯胺 (R-NH2) 蛋白质、修饰有胺基的寡核苷酸及其他含胺结构。其与蛋白质或抗体结合后，展现鲜明的红色荧光（λex=545 nm，λem=560 nm）。
T81669	NKG2D-IN-2
	NKG2D-IN-2（化合物47）为NKG2D抑制剂，其IC50在NKG2D/MICA及ULBP6 TR-FRET测定中分别为0.1 µM与0.2 µM。
T37174	SARS-CoV MPro-IN-1
	MProinhibitor 11b is an inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (MPro; IC50= 0.04 μM in a TR-FRET assay).1It reduces viral yield in the culture supernatant of SARS-CoV-2-infected Vero E6 cells (EC50= 0.72 μM). MProinhibitor 11b also reduces viral RNA copy numbers in the same model when used at concentrations ranging from 1.85 to 50 μM. 1.Dai, W., Zhang, B., Jiang, X.-M., et al.Structure-based design of antiviral drug candidates targeting the SARS-C...